Related Experiment Videos
Is relapse a justification for the use of high-dose antipsychotics?
The Journal of Clinical Psychiatry
|November 1, 1990
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
HORMONE STUDIES WITH THE ULTRACENTRIFUGE : I. AN IMPROVED AIR-DRIVEN VACUUM ULTRACENTRIFUGE SUITABLE FOR CONCENTRATION WORK IN BIOLOGICAL EXPERIMENTS.
The Journal of experimental medicine·2009
The Texas Medication Algorithm Project (TMAP) schizophrenia algorithms.
The Journal of clinical psychiatry·1999
Implementing effectiveness research and improving care for schizophrenia in real-world settings.
The American journal of managed care·1999
Medication treatment for the severely and persistently mentally ill: the Texas Medication Algorithm Project.
The Journal of clinical psychiatry·1999
The Texas Medication Algorithm Project: development and implementation of the schizophrenia algorithm.
Psychiatric services (Washington, D.C.)·1999
Localization of p35 (annexin I, lipocortin I) in normal adult rat kidney and during recovery from ischemia.
Journal of cellular physiology·1992
Pharmacokinetics of Viloxazine ER (Viloxazine Extended-Release Capsules) in Breast Milk of Healthy Lactating Women.
The Journal of clinical psychiatry·2026
GLP-1 Receptor Agonists and All-Cause Overdose Risk in Veterans With Type 2 Diabetes and Opioid Use Disorder.
The Journal of clinical psychiatry·2026
Impact of Vagus Nerve Stimulation on Suicidal Ideation in Markedly Treatment-Resistant Major Depression: A RECOVER Study Report.
The Journal of clinical psychiatry·2026
Major Depressive Disorder and PTSD Treatment Outcome in Interpersonal Psychotherapy and Prolonged Exposure.
The Journal of clinical psychiatry·2026
Population Pharmacokinetic and Pharmacodynamic Analysis of Imipenem in Critically Ill Patients Receiving Continuous Renal Replacement Therapy.
Drug design, development and therapy·2026
Medication Safety and Perioperative Risk Management of GLP-1 Receptor Agonists: A Pharmacist-Led Framework for Individualized Care.
Therapeutics and clinical risk management·2026
GLP-1 and GIP class drugs have neuroprotective properties in Alzheimer's and Parkinson's disease.
Frontiers in neuroscience·2026
Multidimensional characterization of heterogeneity in pesticide co-exposure patterns.
Frontiers in chemistry·2026
Frustration brake failure hypothesis of substance use disorders.
Frontiers in psychiatry·2026